Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Arriva Pharmaceuticals logo — Pioneering the future of healthcare with innovative protease...

Arriva Pharmaceuticals

Pioneering the future of healthcare with innovative protease inhibitors for diverse therapeutic needs

Founded 1997 Series D Health Care, Pharmaceutical

General Information

Company Name Arriva Pharmaceuticals
Founded Year 1997
Industries Health Care, Pharmaceutical
Funding Stage Series D
Social

Get notified when Arriva Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Arriva Pharmaceuticals

Arriva Pharmaceuticals is a biopharmaceutical company established in 1997 with a vision to revolutionize healthcare by developing innovative protease inhibitors for various therapeutic needs. The company's focus areas encompass a wide spectrum of human diseases including respiratory diseases (hereditary emphysema, asthma, COPD, and cystic fibrosis), dermatological diseases (atopic dermatitis, psoriasis), inflammatory ear diseases (otitis media, otitis externa), and oncology (breast cancer, prostate cancer). They have leveraged cutting-edge technology to engineer the large-scale production of stable, non-animal sourced recombinant proteins in yeast. Notably, MPM Capital participated in the Series D investment in July 23, 2004, showcasing confidence in Arriva's potential. The company's rebranding in January 2001 from AlphaOne Pharmaceuticals, Inc. to Arriva Pharmaceuticals, Inc. signifies a strategic shift towards a more diversified drug product pipeline, emphasizing their commitment to innovation and expansion in the pharmaceutical industry.

Taxonomy: biopharmaceutical company, recombinant protease inhibitors, therapeutic focus, respiratory diseases, dermatological diseases, inflammatory ear diseases, oncology, clinical-grade recombinant proteins, GMP, drug product pipeline, large-scale production, disease treatment, pharmaceutical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 1
Investor
23 Jul 2004

Arriva Pharmaceuticals Alternatives & Competitors

Arriva Pharmaceuticals vs
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune dis...

Series B
Biotechnology, Health Care
Arriva Pharmaceuticals vs
BioVascular Inc
BioVascular Inc

Pioneering innovative solutions for platelet-mediated cardiovascular diseases with a groundbreaking...

Series C
2-10 employees
Biotechnology, Health Care
Arriva Pharmaceuticals vs
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. United States

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and dev...

Grant
15 employees
Biotechnology, Health Care

FAQ About Arriva Pharmaceuticals

Pioneering the future of healthcare with innovative protease inhibitors for diverse therapeutic needs
Arriva Pharmaceuticals was founded in 1997.
Arriva Pharmaceuticals operates in the following industries: Health Care, Pharmaceutical.
Arriva Pharmaceuticals has completed 1 funding round. The latest funding stage is Series D.
Top alternatives and competitors to Arriva Pharmaceuticals include VentiRx Pharmaceuticals, BioVascular Inc, Hawaii Biotech, Inc., Protalix Biotherapeutics, Natsar Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arriva Pharmaceuticals and VentiRx Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arriva Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy